Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective
- PMID: 26621825
- DOI: 10.1136/postgradmedj-2015-133281
Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective
Abstract
Diabetes mellitus is a complex metabolic disorder associated with an increased risk of microvascular and macrovascular disease; its main clinical characteristic is hyperglycaemia. The last century has been characterised by remarkable advances in our understanding of the mechanisms leading to hyperglycaemia. The central role of insulin in glucose metabolism regulation was clearly demonstrated during the early 1920s, when Banting, Best, Collip and Macleod successfully reduced blood glucose levels and glycosuria in a patient treated with a substance purified from bovine pancreata. Later, during the mid-1930s, clinical observations suggested a possible distinction between 'insulin-sensitive' and 'insulin-insensitive' diabetes. Only during the 1950s, when a reliable measure of circulating insulin was available, was it possible to translate these clinical observations into pathophysiological and biochemical differences, and the terms 'insulin-dependent' (indicating undetectable insulin levels) and 'non-insulin-dependent' (normal or high insulin levels) started to emerge. The next 30 years were characterised by pivotal progress in the field of immunology that were instrumental in demonstrating an immune-mediated loss of insulin-secreting β-cells in subjects with 'insulin-dependent' diabetes. At the same time, new experimental techniques allowing measurement of insulin 'impedance' showed a reduced peripheral effect of insulin in subjects with 'non-insulin-dependent' diabetes (insulin resistance). The difference between the two types of diabetes emerging from decades of observations and experiments was further formally recognised in 1979, when the definitions 'type I' and 'type II' diabetes were introduced to replace the former 'insulin-dependent' and 'non-insulin-dependent' terms. In the following years, many studies elucidated the natural history and temporal contribution of insulin resistance and β-cell insulin secretion in 'type II' diabetes. Furthermore, a central role for insulin resistance in the development of a cluster of cardiometabolic alterations (dyslipidaemia, inflammation, high blood pressure) was suggested. Possibly as a consequence of the secular changes in diabetes risk factors, in the last 10 years the limitation of a simple distinction between 'type I' and 'type II' diabetes has been increasingly recognised, with subjects showing the coexistence of insulin resistance and immune activation against β-cells. With the advancement of our cellular and molecular understanding of diabetes, a more pathophysiological classification that overcomes the historical and simple 'glucocentric' view could result in a better patient phenotyping and therapeutic approach.
Keywords: DIABETES & ENDOCRINOLOGY; HISTORY (see Medical History).
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Similar articles
-
Historical developments in the drug therapy of diabetes.Orthop Nurs. 1997 Mar-Apr;16(2):81-7. Orthop Nurs. 1997. PMID: 9155419
-
Insulin detemir: A historical perspective on a modern basal insulin analogue.Prim Care Diabetes. 2010 Apr;4 Suppl 1:S31-42. doi: 10.1016/S1751-9918(10)60007-1. Prim Care Diabetes. 2010. PMID: 20394890
-
Landmarks in diabetes care: a historical perspective.Community Nurse. 1998 Jul;4(6):13-6. Community Nurse. 1998. PMID: 9763975
-
Current management of diabetes mellitus and future directions in care.Postgrad Med J. 2015 Nov;91(1081):612-21. doi: 10.1136/postgradmedj-2014-133200. Epub 2015 Oct 9. Postgrad Med J. 2015. PMID: 26453594 Review.
-
Protection of pancreatic beta-cells: is it feasible?Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. doi: 10.1016/j.numecd.2007.05.004. Nutr Metab Cardiovasc Dis. 2008. PMID: 18096375 Review.
Cited by
-
Long-Term Adherence to the Mediterranean Diet Reduces 20-Year Diabetes Incidence: The ATTICA Cohort Study (2002-2022).Metabolites. 2024 Mar 25;14(4):182. doi: 10.3390/metabo14040182. Metabolites. 2024. PMID: 38668310 Free PMC article.
-
Contribution of environmental determinants to the risk of developing type 2 diabetes mellitus in a life-course perspective: a systematic review protocol.Syst Rev. 2024 Mar 1;13(1):80. doi: 10.1186/s13643-024-02488-2. Syst Rev. 2024. PMID: 38429833 Free PMC article.
-
Recent advances in the precision control strategy of artificial pancreas.Med Biol Eng Comput. 2024 Jun;62(6):1615-1638. doi: 10.1007/s11517-024-03042-x. Epub 2024 Feb 28. Med Biol Eng Comput. 2024. PMID: 38418768 Review.
-
Risk factors for falls in older adults with diabetes mellitus: systematic review and meta-analysis.BMC Geriatr. 2024 Feb 28;24(1):201. doi: 10.1186/s12877-024-04668-0. BMC Geriatr. 2024. PMID: 38413865 Free PMC article.
-
Comparative Analysis of COVID-19 Outcomes in Type 1 and Type 2 Diabetes: A Three-Year Retrospective Study.Medicina (Kaunas). 2024 Jan 25;60(2):210. doi: 10.3390/medicina60020210. Medicina (Kaunas). 2024. PMID: 38399498 Free PMC article.